235 related articles for article (PubMed ID: 11575459)
21. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.
Tatsumi C; Kudo M; Ueshima K; Kitai S; Takahashi S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Akiko T; Takeshi M
Intervirology; 2008; 51 Suppl 1():27-33. PubMed ID: 18544945
[TBL] [Abstract][Full Text] [Related]
22. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
Bentsen KD; Henriksen JH; Bendtsen F; Hørslev-Petersen K; Lorenzen I
Hepatology; 1990 Jun; 11(6):957-63. PubMed ID: 2365293
[TBL] [Abstract][Full Text] [Related]
23. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake.
Niemelä O; Risteli J; Blake JE; Risteli L; Compton KV; Orrego H
Gastroenterology; 1990 Jun; 98(6):1612-9. PubMed ID: 1692550
[TBL] [Abstract][Full Text] [Related]
24. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
Wang T; Wang B; Liu X
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
[TBL] [Abstract][Full Text] [Related]
25. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.
Torres-Salinas M; Parés A; Caballería J; Jiménez W; Heredia D; Bruguera M; Rodés J
Gastroenterology; 1986 May; 90(5 Pt 1):1241-6. PubMed ID: 3007261
[TBL] [Abstract][Full Text] [Related]
26. [Possibility of Using ELF Score as Index for Hepatic Fibrosis Evaluation].
Asano H
Rinsho Byori; 2015 Jan; 63(1):78-83. PubMed ID: 26524882
[TBL] [Abstract][Full Text] [Related]
27. [Possibility of early diagnosis of hepatic fibrosis in chronic alcoholics determining the N-terminal peptide of type-III procollagen].
Ricciardi R; Restuccia G
Quad Sclavo Diagn; 1988; 24(1-4):171-8. PubMed ID: 3077474
[TBL] [Abstract][Full Text] [Related]
28. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.
Guéchot J; Poupon RE; Giral P; Balkau B; Giboudeau J; Poupon R
J Hepatol; 1994 Mar; 20(3):388-93. PubMed ID: 8014451
[TBL] [Abstract][Full Text] [Related]
29. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis.
Murawaki Y; Ikuta Y; Nishimura Y; Koda M; Kawasaki H
J Gastroenterol Hepatol; 1996 May; 11(5):443-50. PubMed ID: 8743916
[TBL] [Abstract][Full Text] [Related]
30. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
[TBL] [Abstract][Full Text] [Related]
31. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver.
Raedsch R; Stiehl A; Sieg A; Walker S; Kommerell B
Gastroenterology; 1983 Dec; 85(6):1265-70. PubMed ID: 6628925
[TBL] [Abstract][Full Text] [Related]
32. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
[TBL] [Abstract][Full Text] [Related]
33. Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis.
Schuppan D
J Hepatol; 1991; 13 Suppl 3():S17-25. PubMed ID: 1815006
[TBL] [Abstract][Full Text] [Related]
34. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: relation to clinical symptoms, liver histopathology and outcome.
Nyberg A; Lindqvist U; Engström-Laurent A
J Intern Med; 1992 May; 231(5):485-91. PubMed ID: 1602286
[TBL] [Abstract][Full Text] [Related]
35. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
36. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease.
Nouchi T; Worner TM; Sato S; Lieber CS
Alcohol Clin Exp Res; 1987 Jun; 11(3):287-91. PubMed ID: 3307495
[TBL] [Abstract][Full Text] [Related]
37. Is the aminoterminal propeptide of type III procollagen degraded in the liver? A study of type III procollagen peptide in serum during liver transplantation in pigs.
Bentsen KD; Boesby S; Kirkegaard P; Hansen CP; Jensen SL; Hørslev-Petersen K; Lorenzen I
J Hepatol; 1988 Apr; 6(2):144-50. PubMed ID: 3045193
[TBL] [Abstract][Full Text] [Related]
38. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
[TBL] [Abstract][Full Text] [Related]
39. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease.
Tran A; Hastier P; Barjoan EM; Demuth N; Pradier C; Saint-Paul MC; Guzman-Granier E; Chevallier P; Tran C; Longo F; Schneider S; Piche T; Hebuterne X; Benzaken S; Rampal P
Gastroenterol Clin Biol; 2000; 24(6-7):626-30. PubMed ID: 10962384
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.
Tanaka Y; Minato Y; Hasumura Y; Takeuchi J
Dig Dis Sci; 1986 Jul; 31(7):712-7. PubMed ID: 3720468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
